A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease

Author:

Jung Mungyo1,Lee Songmin2,Park Sohui2,Hong Jihye3,Kim Cheesue1,Cho Illhwan2,Sohn Hee Su1,Kim Kyunghwan2,Park In Wook2,Yoon Soljee24,Kwon Sungpil1,Shin Jisu2,Lee Donghee2,Kang Mikyung3,Go Seokhyung3,Moon Sangjun1,Chung Yeonseok5,Kim YoungSoo24,Kim Byung‐Soo136ORCID

Affiliation:

1. School of Chemical and Biological Engineering Seoul National University Seoul 08826 Republic of Korea

2. Department of Pharmacy Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy Yonsei University Incheon 21983 Republic of Korea

3. Interdisciplinary Program for Bioengineering Seoul National University Seoul 08826 Republic of Korea

4. Department of Integrative Biotechnology and Translational Medicine Yonsei University Incheon 21983 Republic of Korea

5. Laboratory of Immune Regulation Research Institute of Pharmaceutical Sciences Seoul National University Seoul 08826 Republic of Korea

6. Institute of Chemical Processes Institute of Engineering Research BioMAX Seoul National University Seoul 08826 Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3